Listing

• Advised Guizhou Zhenhua Fengguang Semiconductor Co., Ltd. (688439.SH) on its listing

• Advised Beijing Tongyi Zhongxin Materials Technology Co., Ltd. (688722.SH) on its listing

• Advised Aojing Medical Technology Co., Ltd. (688613.SH) on its listing

• Advised Hengyu Xintong Aviation Equipment (Beijing) Co., Ltd. (300965.SZ) on its listing

• Advised Beijing Quanshi Tiandi Online Network Information Co., Ltd. (002995.SZ) on its listing

M&A, Refinancing, and Restructuring of Listed Companies

• Advised China Petroleum (601857.SH) on the restructuring of its domestic pipeline business and its investment in national pipeline projects

• Advised Beijing Tongyi Zhongxin Materials Technology Co., Ltd. (688722.SH)  on its acquiring control of Yancheng Youhebo New Materials Co., Ltd.

• Advised Cisco Rui (688053.SH) on its acquiring control of Shaanxi Haice Electronics Technology Service Co., Ltd.

• Advised Triangle Defense (300775.SZ) on its refinancing 

• Advised China Nuclear Power (601985.SH) on its refinancing

• Advised Baoti Group (600456.SH) on its refinancing

• Advised Dagg Road Machinery (300103.SZ) on its restructuring

• Advised China Railway (601390.SH) on its refinancing

• Advised Jinyu Group (601992.SH) on its acquiring Tangshan Jidong Development Co., Ltd., and indirect acquisition of Tangshan Jidong  Cement Co., Ltd. (000401.SZ)

• Advised Sinopec (600028.SH) on its refinancing and restructuring of its overseas subsidiary

• Advised Changling Co., Ltd. (000561.SZ) on its refinancing and restructuring

• Advised Shaanxi Guotou (000563.SZ) on its restructuring

• Advised Hong Kong Cheung Kong Industries and Hutchison Whampoa on their merger, restructuring, and listing

Medical/Biotech/Pharmaceutical/Life Sciences Industry

• Advised ArtSurgical Medical Technology (Suzhou) Co., Ltd. (surgical robotics) on its equity investment

• Advised Shanghai MicroPort CardioFlow MedTech Ltd. (research, development, production, and sales of VitaFlow transcatheter aortic valve and delivery systems) on its Series B equity investment 

• Advised Shanghai Yinosi Biotechnology Co., Ltd. (preclinical safety assessment research services for pharmaceutical institutions worldwide) on its equity investment

• Advised Shanghai Ailis Pharmaceutical Technology Co., Ltd. (innovative drug development and production for hypertension, oncology, diabetes, etc.) on its equity investment

• Advised Shanghai Aohua Endoscopy Co., Ltd. (medical endoscopes and related products) on its equity investment 

• Advised Anlong Gene Pharmaceutical Technology Co., Ltd. (gene therapy) on its equity investment

• Advised Beijing G-Eno Gene Technology Co., Ltd. (genetic testing) on its equity investment

• Advised Shanghai Huihe Medical Technology Co., Ltd. (tricuspid valve repair products for cardiac applications) on its equity investment

• Advised Chasen Medical Devices (Tianjin) Co., Ltd. (orthopedic implant products) on its equity investment

• Advised Wuxi Shangwo Medical Electronics Co., Ltd. (breath-based molecular diagnostic biosensor medical electronic products) on its equity investment

• Advised Cangzhou Four Stars Glass Co., Ltd. (medical neutral borosilicate glass tubing, oral glass bottles, and anatomical bottles) on its equity investment

• Advised Yichang Dongyangguang Pharmaceutical Co., Ltd. (active pharmaceutical ingredients) and Ruyuan Dongyangguang Pharmaceutical Co., Ltd. (active pharmaceutical ingredients) on its equity investment

• Advised Beijing Kandehong Trading Development Co., Ltd. and Beijing Yingchuangbaili Technology Development Co., Ltd. (sales of large-scale medical equipment in the radiological field, medical consumables, rental of medical equipment, and equipment management and maintenance services) on its equity investment

Military and Defense Industry Capital Operations and Financing

• Advised China Changzheng Rocket Co., Ltd. (space launch services and payload system design) on its equity investment

• Advised Beijing Future Navigation Technology Co., Ltd. (Beidou satellite low-orbit navigation enhancement system and satellite constellation) on its equity investment

• Advised Beijing Maniu Technology Co., Ltd. (big data analysis and applications in public safety) on its equity investment

• Advised Chengdu Rongxing Technology Co., Ltd. (radio signal monitoring and information processing) on its equity investment

• Advised Xingzhan Measurement & Control Technology Co., Ltd. (satellite communication antennas for vehicles, ships, and aircraft) on its equity investment

• Advised Topwiz Electronics Technology (Shanghai) Co., Ltd. (chip research and development for digital and RF chips) on its equity investment

• Advised Changchun Tongshi Optoelectronic Technology Co., Ltd. (optoelectronic systems including dynamic base imaging, axis stabilization, and target aiming) on its equity investment

• Advised Shenzhen Kexin Technology Co., Ltd. (electronic information equipment for communication and meteorological detection fields) on its equity investment

• Advised on the subscription of the non-publicly issued shares in Zhongtung High-Tech Materials Co., Ltd. (development of rare metals and deep processing products)

• Advised on the subscription of the non-publicly issued shares in Shanghai Sinan Satellite Navigation Technology Co., Ltd. (the first domestic enterprise fully mastering core technology for high-precision Beidou/GNSS receiver modules)